Filed Under: , Tickers in this Article: ISRG, PHG, GE, HOLX,
ARAY, SI, SYK, BAX You can follow medical technology for a long
time and not find too many growth stories like Intuitive
Surgical (Nasdaq:ISRG). I know because I've been following this
sector for more than a decade, and there haven't been many
others like this one. Here you have a rare combination of
incredible growth, virtually no competition and a clear clinical
benefit to the product.  And yet, the stock is down almost 50%
from its 52-week high. Not only is the valuation quite high
(even granting that it's a top performer), but skeptics are just
waiting for the signs that the growth story is going to crack.
So, given that we're in the middle of a nasty market correction
and the company didn't report an absolutely 100% spotless
report, I'm not all that surprised to see the stock trade off
following earnings.  Dissecting the Earnings Report Selloff Once
again, Intuitive Surgical delivered the goods with its earnings
report. Revenue jumped more than